Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07225738 · ClinicalTrials.gov registry record
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
A clinical trial of Multiple Myeloma, sponsored by City of Hope Medical Center.
- Recruiting
- Registry status
- 700
- Enrollment target
- 11
- Study locations
NCT07225738 is a study of Multiple Myeloma that is actively recruiting participants, run by City of Hope Medical Center. The registered enrollment target is 700 participants, above the 545-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (28% higher). The trial reports 11 study locations across 4 states.
The verdict
NCT07225738, a study of Multiple Myeloma, is actively recruiting participants, sponsored by City of Hope Medical Center.
- RECRUITING
- Registry status
- 700 participants
- Enrollment target
- 11
- Study locations
Study Summary
This study assesses the impact of cannabis (also commonly called marijuana, weed, or THC) use on quality of life among patients with multiple myeloma who are receiving chemotherapy. It also evaluates the potential benefits and harms of cannabis use.
Conditions Studied
Interventions
- OTHER Non-Interventional Study
Study Locations (11)
California
- City of Hope Medical Center - Duarte
- City of Hope Seacliff - Huntington Beach
- City of Hope at Irvine Lennar - Irvine
- City of Hope at Long Beach Elm - Long Beach
- City of Hope at Newport Beach Fashion Island - Newport Beach
- City of Hope South Pasadena - South Pasadena
- City of Hope Upland - Upland
- City of Hope West Covina - West Covina
Arizona
- CTCA at Western Regional Medical Center - Goodyear
Georgia
- City of Hope Atlanta Cancer Center - Newnan
Illinois
- City of Hope at Chicago - Zion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2026-01-21 |
| Est. Completion | 2030-08-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07225738
The ClinicalTrials.gov registry entry for NCT07225738 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 700 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 545-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (28% higher). The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Multiple Myeloma appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT07225738 reports 11 study locations spanning 4 distinct geographic areas - top geographies include California, Arizona, Georgia.
Frequently Asked Questions
What is clinical trial NCT07225738 about?
NCT07225738 is a clinical study titled "A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients". This study assesses the impact of cannabis (also commonly called marijuana, weed, or THC) use on quality of life among patients with multiple myeloma who are receiving chemotherapy. It also evaluates the potential benefits and harms of cannabis use.
What is the current status of trial NCT07225738?
This trial is currently recruiting. The enrollment target is 700 participants. The study started on 2026-01-21. Estimated completion is 2030-08-22.
What conditions does trial NCT07225738 study?
This clinical trial studies the following conditions: Multiple Myeloma.
What interventions are being tested in trial NCT07225738?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT07225738?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07225738 being conducted?
This trial has 11 study locations across Arizona, California, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Myeloma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant
RECRUITING · Phase 2
-
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
RECRUITING · Phase 1
-
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
RECRUITING · NA
-
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
RECRUITING
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.